Macro Finance
Ozempic-maker sues rival over false advertising
BBC Business·July 21, 2026·1 min read
Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising. The lawsuit targets alleged misleading claims by Eli Lilly in the competitive weight-loss drug market. Novo Nordisk seeks to protect its market position through this legal challenge.
Read at BBC BusinessDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.